ABC | Volume 113, Nº6, Dezembro 2019

Artigo Original Celebi et al. NT-pro BNP e aneurisma do ventrículo esquerdo Arq Bras Cardiol. 2019; 113(6):1129-1137 1. Shen WF, Tribouilloy C, Mirode A, Dufossé H, Lesbre JP. Left ventricular aneurysm and prognosis in patients with first acute transmural anterior myocardial infarction and isolated left anterior descending artery disease. Eur Heart J. 1992;13(1):39-44 2. Faxon DP, Ryan TJ, Davis KB, McCabe CH, Myers W, Lesperance J, et al.Prognostic significance of angiographically documented left ventricular aneurysm from the Coronary Artery Surgery Study (CASS). Am J Cardiol. 1982;50(1):157-64 3. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end- diastolic pressure in patients with symptomatic left ventricular dysfunction. AmHeart J. 1998;135(5 Pt 1):825-32. 4. Bassan R, Potsch A, Maisel A, Tura B, Villacorta H, Nogueira MV, et al. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J. 2005;26(3):234-40. 5. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 1998;97(19):1921-9. 6. Verouden NJ, Haeck JD, Kuijt WJ, van Geloven N, Koch KT, Henriques JP, et al. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention. Am J Cardiol. 2010;105(8):1047-52. 7. Sabatine MS, Morrow DA, de Lemos JA, Omland T, Desai MY, Tanasijevic M, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol. 2004;44(10):1988-95. 8. Omland T, Persson A, Ng L, O’Brien R, Karlsson T, Herlitz J, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation. 2002;106(23):2913-8. 9. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33(20):2551-67. 10. WeymanAE,PeskoeSM,WilliamsES,Dillon JC,FeigenbaumH.Detectionof left ventricular aneurysms by cross-sectional echocardiography. Circulation. 1976;54 (6):936-44. 11. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81. 12. DubnowMH, Burchell HB, Titus JL. Postinfarction ventricular aneurysm. A clinicomorphologic and electrocardiographic study of 80 cases. Am Heart J. 1965; 70(6):753. 13. Glower DG, Lowe EL. Left ventricular aneurysm. In: Edmunds LH (ed). Cardiac surgery in the adult. New York: McGraw Hill;1997. 14. Forman MB, Collins HW, Kopelman HA, Vaughn WK, Perry JM, Virmani R, et al. Determinants of left ventricular aneurysm formation after anterior myocardial infarction: a clinical and angiographic study. J Am Coll Cardiol. 1986;8(6):1256-62. 15. Tikiz H, Atak R, Balbay Y, Genç Y, Kütük E. Left ventricular aneurysm formation after anterior myocardial infarction: clinical and angiographic determinants in 809 patients. Int J Cardiol. 2002;82(1):7-14. 16. Mariotti R, Petronio AS, Robiglio L, Balbarini A, Mariani M. Left ventricular aneurysm:clinicalandhemodynamicdata.ClinCardiol. 1990;13(12):845-50. 17. Hirai T, Fujita M, Nakajima H, Asanoi H, Yamanishi K, Ohno A, et al. Importance of collateral circulation for prevention of left ventricular aneurysm formation in acute myocardial infarction. Circulation. 1989;79(4):791-6. 18. Mayr A, Mair J, SchockeM, Klug G, Pedarnig K, Haubner BJ, et al. Predictive value of NT-pro BNP after acute myocardial infarction: relation with acute and chronic infarct size and myocardial function. Int J Cardiol. 2011;147(1):118-23. 19. Kleczy ń ski P, Legutko J, Rakowski T, Dziewierz A, Siudak Z, Zdzienicka J, et al. Predictive utility of NT-pro BNP for infarct size and left ventricle function after acute myocardial infarction in long-term follow-up. Dis Markers. 2013;34(3):199-204 20. Fazlinezhad A, Rezaeian MK, Yousefzadeh H, Ghaffarzadegan K, Khajedaluee M. Plasma Brain Natriuretic Peptide (BNP) as an Indicator of Left Ventricular Function, Early Outcome and Mechanical Complications after AcuteMyocardial Infarction. ClinMed Insights Cardiol. 2011;5:77-83. 21. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acutemyocardial infarction. Circulation. 1995;92(6):1558-64 22. Tateishi J, Masutani M, Ohyanagi M, Iwasaki T.Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol. 2000;23(10):776-80. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 1137